
How Compass Empowered a Rare Disease and Gene Therapy Pioneer in Their IND-Enabling Studies
Therapeutics companies at the forefront of rare disease research often find themselves navigating a complex maze of scientific innovation, regulatory requirements, and resource constraints. These